Channelrhodopsin: A protein tool being used to help our brain understand itself

Channelrhodopsin: A protein tool being used to help our brain understand itself

from a talk on the NMDA receptor & memory at Zeneca Pharmaceuticals 1992. R. Mott

from Sophie’s World by Jostein Gaarder


Few proteins have had as profound an impact on modern biology as channelrhodopsin. What began as an investigation into how microscopic green algae sense and respond to light ultimately led to one of the most transformative technologies in neuroscience: optogenetics.

Today, channelrhodopsins allow researchers to control the activity of specific neurons with millisecond precision using light, enabling experiments that were previously impossible. The impact of this technology was recognized with the 2026 Nobel Prize for Medicine.

From a protein biochemistry perspective, channelrhodopsins are fascinating molecules. They combine a light-sensing chromophore with an ion channel in a single protein, directly converting photons into electrical signals without requiring intermediary signaling pathways. This elegant molecular design explains both their biological function in algae and their extraordinary utility as research tools to drive our understanding of how the human brain actually works.

It all began with the unicellular green alga Chlamydomonas reinhardtii, a photosynthetic microorganism that can actively swim toward or away from light sources, a behavior known as phototaxis.

Researchers in the 1970s and 1980s sought to understand the molecular basis of this light-guided movement. Physiological studies demonstrated that illumination of the algal eyespot triggered rapid changes in membrane potential and ion fluxes, suggesting the presence of a specialized photoreceptor linked to ion transport.

A major clue emerged from studies of microbial rhodopsins. Bacteriorhodopsin and halorhodopsin had already been identified in archaea as retinal-containing membrane proteins capable of light-driven ion transport. Scientists suspected that a related class of proteins might exist in algae.

The breakthrough came in the early 2000s when genomic and electrophysiological investigations identified two novel photoreceptor proteins in C. reinhardtii:

  • Channelrhodopsin-1 (ChR1)
  • Channelrhodopsin-2 (ChR2)

In 2002, Nagel and colleagues demonstrated that Channelrhodopsin-1 functions as a light-gated ion channel. Shortly thereafter, Channelrhodopsin-2 was shown to mediate rapid light-induced cation conductance. These findings revealed an entirely new type of photoreceptor: a single-component protein that directly converts light into ion flux.

Unlike vertebrate visual rhodopsins, which activate G-protein signaling cascades, channelrhodopsins operate as much simpler, self-contained molecular machines.

The full story of these initial observations, the subsequent studies into the underlying mechanism via the ChR1 and 2 proteins and how the proteins ultimately ended up as the tools powering the engine of Optogenetics is beautifully described in this Nobel Prize announcement article.

It is a wonderful  scientific journey, beginning with Hegemann’s curiosity to understand how algae sense light, followed by Nagel’s work identifying the proteins underlying these responses and uncovering the mechanism.  The final “creative” moment, demonstrating the power of cross functional collaboration, came when Desseroth and colleagues recognized that channelrhodopsins could be used to trigger electrical impulses in nerve cells. The subsequent development of methods to make this work in living animals laid the foundations for optogenetics.

Structure of channelrhodopsin
Figure 1: The X-ray crystallography structure of C. reinhardtii channelrhodopsin (PDB : 3UG9)

A Retinal-Binding Membrane Protein

Channelrhodopsins belong to the microbial rhodopsin superfamily. Like other rhodopsins, they contain:

  • Seven transmembrane α-helices
  • A covalently bound retinal chromophore, derived from vitamin A that serves as the light-absorbing component of the protein.
  • Conserved amino acids that coordinate retinal and govern photochemistry

Significant progress in understanding channelrhodopsin function came from structural biology, with the first high-resolution crystal structure of a channelrhodopsin being reported in 2012.

Beyond simply revealing the architecture of the protein, these studies helped explain how absorption of light by retinal is coupled to opening of the ion-conducting pore. As an integral membrane protein, however, channelrhodopsin presented many of the challenges familiar to structural biologists, including recombinant expression, extraction from lipid membranes and maintenance of stability outside its native environment.

To solve this initial structure Kato et al., (2012) screened a number of engineered channelrhodopsin constructs from C. reinhardtii and other organisms. The successful construct was a chimeric version of C. reinhardtii channelrhodopsin that they named C1C2, which consisted of ChR1 without the C terminus, with the last two TM regions exchanged for those from ChR2. At the C-terminus a TEV-eGFP-8His tag was added. The eGFP for use in the initial construct screening in HEK293 cells using fSEC and the His tag to aid purification. To support the crystallization studies this construct was expressed in baculovirus infected Sf+ insect cells and purified following solubilization of the membrane fraction.

This and subsequent structural studies provided direct insights into:

  • Retinal positioning: Which is attached via a protonated Schiff base linkage to a lysine residue within the protein.
  • Pore architecture: With multiple constriction sites identified within the pore that regulate ion permeation.
  • Ion-conducting pathways: Unlike highly selective ion channels, Channelrhodopsin-2 functions as a relatively non-selective cation channel that displays
    • Fast activation
    • Moderate conductance
    • Broad cation permeability
  • Gating mechanisms: Gating involves coordinated movement of residues within the transmembrane bundle, creating transient aqueous pathways through the protein.

This combination of features makes channelrhodopsin particularly effective at depolarizing cells. In native algae, this depolarization triggers those behavioral responses to light that Hegemann and others had observed.

The Photocycle

The central biochemical event underlying channelrhodopsin function is retinal photoisomerization.

In the dark state:

  • Retinal exists predominantly in the all-trans configuration.
  • The ion channel remains closed.

Upon absorption of a photon:

  • Retinal rapidly isomerizes.
  • Structural rearrangements propagate through the transmembrane helices.
  • The channel pore opens.

This process occurs on the microsecond timescale, and the resulting open state permits the passage of cations including: H⁺, Na⁺, K⁺ and Ca²⁺. The protein subsequently progresses through a series of photointermediates before returning to its original dark state.

The complete photocycle occurs within milliseconds, allowing repeated stimulation at high frequencies. And it is this rapid response that was one of the key factors that meant that channelrhodopsins were ideal to be developed as tools for use in the new field of optogenetics.

Subsequent cryo-electron microscopy and crystallographic studies on the C. reinhardtii and other related channelrhodopsins have revealed how subtle amino acid substitutions can dramatically alter:

  • Absorption wavelength
  • Kinetic behavior
  • Ion selectivity
  • Light sensitivity

This structural understanding laid the foundation for protein engineering efforts that transformed channelrhodopsins into versatile optogenetic tools. (See later for more detail)

The cryoEM structure of Kalium channelrhodopsin 1 C110A mutant from Hyphochytrium catenoides, Dark State
Figure 2: The cryo-EM structure of Kalium channelrhodopsin 1 from Hyphochytrium catenoides, Dark State (PDB : 9CDC)

The Birth of Optogenetics

Although the algal proteins themselves were fascinating, their greatest impact came from an unexpected application, described more fully in the Nobel Prize announcement article.

In 2005, Karl Deisseroth, Edward Boyden and colleagues demonstrated that expression of Channelrhodopsin-2 in mammalian neurons allowed neuronal firing to be controlled by pulses of blue light.

This was a revolutionary concept.

Rather than using electrodes to stimulate neurons:

  1. Introduce the channelrhodopsin gene.
  2. Express the protein in selected cells.
  3. Illuminate with light.
  4. Trigger action potentials with millisecond precision.

The simplicity of the system was unprecedented because channelrhodopsin required only:

  • The protein itself
  • Endogenous retinal already present in mammalian tissues

No additional signaling components were necessary.

The technology quickly became known as optogenetics, combining optical control with genetic targeting.

The concept was remarkably simple, but its impact was transformative. For the first time, researchers could selectively activate specific neurons within a living animal and directly observe the effects on behavior. Neuroscience could move beyond observing correlations and begin testing cause and effect.

Why Channelrhodopsin Was Ideal for Optogenetics

From a protein science perspective, channelrhodopsin is particularly elegant. Unlike many biological signaling systems that require multiple proteins, channelrhodopsin combines light sensing and ion channel activity within a single seven-transmembrane protein, making it both mechanistically fascinating and highly amenable to experimental study.

Several biochemical properties made channelrhodopsin uniquely suitable.

Single-Component Functionality

  • Many signalling proteins require complex accessory pathways.
  • Channelrhodopsin functions independently, making heterologous expression straightforward.

Fast Kinetics

  • Neurons communicate on the millisecond timescale.
  • Channelrhodopsin activation and deactivation kinetics are similarly rapid, enabling faithful control of neural firing patterns.

Direct Electrical Control

  • The protein directly conducts ions rather than activating secondary messengers.
  • This creates predictable and reproducible membrane depolarization.

Genetic Targetability

  • The channelrhodopsin gene can be placed under cell-type-specific promoters.
  • This enables selective control of defined neuronal populations.

Engineering Better Channelrhodopsins

The original Channelrhodopsin-2 molecule was remarkably effective but based on the cryo-EM and X-ray structure data, researchers soon began engineering variants with improved properties, generating an extensive toolbox tailored for specific experimental needs to progress the optogenetics field.

Examples include:

  • H134R: An early mutation that increased photocurrents and improved expression.
  • ChETA: Variants with faster closing kinetics that enable high-frequency neuronal stimulation.
  • C1V1: Red-shifted channelrhodopsins activated by longer wavelengths of light that penetrate tissue more effectively.
  • Chrimson: A red-light activated channelrhodopsin that supports deeper tissue stimulation.
  • ChRmine: An ultra-sensitive channelrhodopsin with exceptionally large photocurrents and improved performance for in vivo applications.

Other Applications Beyond Optogenetics

The use of channelrhodopsin tools has branched out to other areas of research. Applications include:

  • Mapping neural circuits
  • Studying memory formation
  • Investigating psychiatric disorders
  • Cardiac electrophysiology
  • Pancreatic β-cell regulation
  • Skeletal muscle control
  • Developmental biology
  • Synthetic biology

Researchers are also exploring therapeutic applications for:

  • Vision restoration: Several clinical programs have investigated channelrhodopsin-based approaches for restoring visual responses in patients suffering from photoreceptor loss.
  • Epilepsy
  • Parkinson’s disease
  • Retinal degeneration

Bibliography and Further Reading

  1. Nobel Prize in Physiology or Medicine 2026. NobelPrize.org. Nobel Prize Outreach 2026. Tue. 6 Oct 2026. https://www.nobelprize.org/prizes/medicine/2026/summary/
  2. Popular information. NobelPrize.org. Nobel Prize Outreach 2026. Mon. 5 Oct 2026. https://www.nobelprize.org/prizes/medicine/2026/popular-information/
  3. Foster, K. W., & Smyth, R. D. (1980). Light antennas in phototactic algae. Microbiological Reviews, 44(4), 572-630.
    DOI: Not assigned.
  4. Harz, H., & Hegemann, P. (1991). Rhodopsin-regulated behavioural responses in the green alga Chlamydomonas. Nature, 351, 489-491.
    DOI: 10.1038/351489a0
  5. Sineshchekov, O. A., Jung, K. H., & Spudich, J. L. (2002). Two rhodopsins mediate phototaxis to low and high light intensities in Chlamydomonas reinhardtii. Proceedings of the National Academy of Sciences USA, 99(13), 8689-8694.
    DOI: 10.1073/pnas.122243399
  6. Nagel, G., Ollig, D., Fuhrmann, M., Kateriya, S., Musti, A. M., Bamberg, E., & Hegemann, P. (2002). Channelrhodopsin-1: A light-gated proton channel in green algae. Science, 296(5577), 2395-2398.
    DOI: 10.1126/science.1072068
  7. Nagel, G., Szellas, T., Huhn, W., Kateriya, S., Adeishvili, N., Berthold, P., Ollig, D., Hegemann, P., & Bamberg, E. (2003). Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proceedings of the National Academy of Sciences USA, 100(24), 13940-13945.
    DOI: 10.1073/pnas.1936192100
  8. Hegemann, P. (2008). Algal sensory photoreceptors. Annual Review of Plant Biology, 59, 167-189.
    DOI: 10.1146/annurev.arplant.59.032607.092847
  9. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., & Deisseroth, K. (2005). Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience, 8(9), 1263-1268.
    DOI: 10.1038/nn1525
  10. Deisseroth, K. (2011). Optogenetics. Nature Methods, 8(1), 26-29.
    DOI: 10.1038/nmeth.f.324
  11. Berndt, A., Yizhar, O., Gunaydin, L. A., Hegemann, P., & Deisseroth, K. (2009). Bi-stable neural state switches. Nature Neuroscience, 12(2), 229-234.
    DOI: 10.1038/nn.2247
  12. Kato, H. E., Zhang, F., Yizhar, O., Ramakrishnan, C., Nishizawa, T., Hirata, K., et al. (2012). Crystal structure of the channelrhodopsin light-gated cation channel. Nature, 482, 369-374.
    DOI: 10.1038/nature10870
  13. Wietek, J., & Prigge, M. (2016). Optogenetic tools derived from microbial rhodopsins. Biological Chemistry, 397(2), 139-149.
    DOI: 10.1515/hsz-2015-0269
  14. Klapoetke, N. C., Murata, Y., Kim, S. S., Pulver, S. R., Birdsey-Benson, A., Cho, Y. K., et al. (2014). Independent optical excitation of distinct neural populations. Nature Methods, 11, 338-346.
    DOI: 10.1038/nmeth.2836
  15. Marshel, J. H., Kim, Y. S., Machado, T. A., Quirin, S., Benson, B., Kadmon, J., et al. (2019). Cortical layer-specific critical dynamics triggering perception. Science, 365(6453), eaaw5202.
    DOI: 10.1126/science.aaw5202
  16. Bedbrook, C. N., Yang, K. K., Robinson, J. E., Mackey, E. D., Gradinaru, V., & Arnold, F. H. (2019). Machine learning-guided channelrhodopsin engineering enables minimally invasive optogenetics. Nature Methods, 16, 1176-1184.
    DOI: 10.1038/s41592-019-0583-8
  17. Marshel, J. H., Callaway, E. M., Raimondo, J. V., et al. (2022). ChRmine enables ultrapotent optogenetic manipulation. Nature, 606, 411-420.
    DOI: 10.1038/s41586-022-2478-5
  18. Deisseroth, K. (2015). Optogenetics: 10 years of microbial opsins in neuroscience. Nature Neuroscience, 18(9), 1213-1225.
    DOI: 10.1038/nn.4091
  19. Fenno, L., Yizhar, O., & Deisseroth, K. (2011). The development and application of optogenetics. Annual Review of Neuroscience, 34, 389-412.
    DOI: 10.1146/annurev-neuro-061010-113817
  20. Govorunova, E. G., Sineshchekov, O. A., Janz, R., Liu, X., & Spudich, J. L. (2015). Natural light-gated anion channels: A family of microbial rhodopsins for advanced optogenetics. Science, 349(6248), 647-650.
    DOI: 10.1126/science.aaa7484
  21. Ernst, O. P., Lodowski, D. T., Elstner, M., Hegemann, P., Brown, L. S., & Kandori, H. (2014). Microbial and animal rhodopsins: Structures, functions, and molecular mechanisms. Chemical Reviews, 114(1), 126-163.
    DOI: 10.1021/cr4003769